Report updated Apr 10, 2026

Accredo is a well-regarded medical app that is completely free. With a 4.8/5 rating from 62.7K reviews, it maintains solid user satisfaction. Users particularly appreciate ease of use and convenience, though order processing and delivery issues remains a common concern.

What Is Accredo?

Accredo is a specialized medical app for patients with chronic conditions, acting as a digital portal for Accredo Health Group's specialty pharmacy services. It differentiates itself through condition-specific clinical support (TRCs) and robust copay assistance tools. While it maintains a high user rating of 4.8 on iOS, it faces significant competition from CVS Specialty's retail ecosystem and digital-first disruptors like Alto Pharmacy.

Ranking Evolution (last 7D · US)

#84
4

Category

MedicalFree

Published by

Accredo Health Group

Accredo
Intel →

Nemesis

CVS Specialty

CVS Specialty

Rivals

OptumRx
Medisafe Medication Management
GoodRx: Prescription Savings
Mora: Journal & Time Capsule

Recent User Mood

Excited
Excited
Ease of Use and Convenience
Order Processing and Delivery Issues

What makes this app unique?

What Does It Look Like?

What's New

v2.36.3

No release notes available.

What Are The Key Features?

Specialty Medication ManagementStandard

Digital portal for ordering refills and tracking specialty medication orders

Therapeutic Resource Centers (TRCs)Differentiator

Access to condition-specific clinical teams including pharmacists and infusion nurses

Copay Assistance ToolDifferentiator

Searchable tool to find financial support programs tailored to specific medications

Dose RemindersDifferentiator

In-app notifications to help patients adhere to their medication schedules

Who is it for & how much does it cost?

Target Audience

Patients managing complex or chronic conditions such as cancer, multiple sclerosis, HIV, or bleeding disorders who require specialized pharmacy support.

Pricing

Free
  • Free for all Accredo specialty pharmacy patients

The app is a value-added service designed to drive patient adherence and operational efficiency for the pharmacy, rather than generating direct revenue.

Who Built It?

Accredo Health Group

View Publisher Intel →
Medical

Enrichment in progress

Publisher profile available very soon

What other apps does Accredo Health Group make?

User Sentiment

iIndependent intel reports to help builders create better apps. Accuracy improves every day. For informational purposes only.

High confidence · 51.6K reviews available

What is the recent mood?

Excited
Excited

Recent user voice shows a excited sentiment. Users appreciate ease of use and convenience and responsive customer service, but report order processing and delivery issues and information discrepancies.

What Users Love

Ease of Use and Convenience

The app is very intuitive.

Accredo has the easiest and fastest way to reorder medications.

Responsive Customer Service

Accredo staff have been excellent and very responsive.

There is a 'live' person to talk if needed 24 hours a day.

What Frustrates Users

Order Processing and Delivery Issues

Tell you that you Will get it a certain day only for it to be cancelled the day it was meant to be received.

You missed 2 prescription refills in the last 60 days.

Information Discrepancies

The app has information discrepancies between order stages and information updates.

The billing portion is confusing on the application.

What is the competitive landscape for Accredo?

How's The Medical Market?

How does it evolve in the Medical market?

ChartRankChange
Free#844

Medical Market Trend

Medical market trend & dynamics

Available very soon

The rivals identified

The Nemesis

CVS Specialty

CVS Specialty

4.4 (2K)

CVS Pharmacy

The most direct market rival, serving as the specialty pharmacy arm for the largest pharmacy chain and PBM (Caremark) in the U.S.

Verdict

Accredo holds a slight edge in pure app satisfaction and clinical depth, but CVS Specialty wins on ecosystem breadth. For patients who value a specialized, high-touch clinical experience, Accredo is the leader; for those valuing convenience and retail access, CVS is the nemesis.

Where CVS Specialty wins

  • -

    Omnichannel flexibility allowing users to bridge digital orders with physical retail support

  • -

    Larger overall market share in the PBM space provides a wider automatic user base

Where Accredo wins

  • +

    Higher user sentiment and rating (4.8 vs 4.6) indicating a more stable mobile experience

  • +

    Condition-specific 'Therapeutic Resource Centers' provide deeper clinical specialization than CVS's generalist approach

Contenders

OptumRx

OptumRx

Optum Inc.

The pharmacy service arm of UnitedHealth Group, competing directly for large-scale employer and health plan specialty contracts.

+

Medicine cabinet feature for managing both specialty and traditional maintenance meds in one view

+

Real-time drug pricing and lower-cost alternative suggestions

Peers

GoodRx: Prescription Savings

GoodRx: Prescription Savings

GoodRx

While not a pharmacy, it is the primary tool specialty patients use to navigate the high costs and find financial assistance for their medications.

+

Comprehensive database of manufacturer coupons and patient assistance programs

+

Price transparency across almost every U.S. pharmacy

New Kids on the Block

Mora: Journal & Time Capsule

Mora: Journal & Time Capsule

Ethan Bakker

A rapidly growing digital pharmacy that emphasizes a frictionless mobile experience for chronic and complex medication users.

+

Predictive refills and automated doctor coordination

+

Clean, modern UI that removes the 'medical' feel of traditional pharmacy apps

The outtake for Accredo

SWOT Analysis

Core Strengths

  • High user sentiment and stable mobile experience (4.8 rating)
  • Condition-specific clinical specialization via TRCs
  • Robust in-app copay assistance navigation tools

Critical Frictions

  • Critical failures in order fulfillment synchronization
  • Confusing billing UI and information discrepancies
  • Lack of omnichannel flexibility compared to retail-linked rivals

Growth Levers

  • Implement real-time courier tracking to match Alto Pharmacy
  • Add in-app secure messaging with specialty care teams (Nemesis feature)
  • Expand to a full 'Medicine Cabinet' view for all patient medications

Market Threats

  • CVS Specialty's vertical integration with Aetna and retail pickup
  • Digital-first pharmacies (Alto, Capsule) with superior delivery UX
  • OptumRx's focus on cost-containment for large employer contracts

What are the next best moves?

high

Audit and fix backend data synchronization for order status

Top complaint theme regarding orders being cancelled on delivery day without prior app notification, causing significant patient distress.

medium

Implement real-time delivery tracking/courier updates

Identified as a key differentiator for 'New Kid' competitor Alto Pharmacy; addresses the 'Order Processing' complaint theme.

medium

Redesign the billing and prescription list UI

Users reported the billing portion is 'confusing' and that the app fails to list all active prescriptions.

Feature Gaps vs Competitors

  • Retail pickup integration (available in CVS Specialty)
  • Real-time courier delivery tracking (available in Alto Pharmacy)
  • In-app secure messaging with care teams (available in CVS Specialty and Alto)
  • Medicine cabinet for non-specialty meds (available in OptumRx)

Key Takeaways

Accredo is the clinical leader in the specialty pharmacy app space, outperforming CVS Specialty in user satisfaction. However, it faces a critical risk from backend data discrepancies that lead to unexpected order cancellations, a failure point that digital-first competitors like Alto are exploiting with superior delivery transparency.

Where Is It Heading?

Stable

Last updated April 2026 with enhanced copay tools — indicates active feature investment, not maintenance mode.

High rating (4.8) but stable ranking (#88) — suggests strong retention of existing users but limited aggressive growth.

Persistent complaints about order cancellations — indicates a disconnect between digital UX and physical fulfillment.

Independent intel to help builders create better apps.

No publisher influence. No third-party bias. Built with objectivity in mind to serve the builder community.

Hope this helps & keep building! · Found an error?

What's new in this report

No changes detected yet.

Cite this report

Marlvel.ai. “Accredo Intelligence Report.” Updated Apr 10, 2026. https://marlvel.ai/intel-report/medical/com-accredohealth-accredo-mobile

Agent Markdown (.md)·

Data licensed under CC-BY-NC 4.0